Moderna Inc. has officially filed its application for an emergency use authorization (EUA) for its COVID-19 vaccine in the Philippines.
The application was submitted by Zuellig Pharma Corp. on behalf of Moderna, making it the eighth vaccine company to apply for EUA in the country.
The Philippine FDA stated that the review process for Moderna's vaccine could be expedited due to prior EUAs from stringent regulatory authorities.
If approved, initial doses of Moderna's vaccine are expected to arrive in the Philippines between May and June, with the government securing 13 million doses and the private sector ordering 7 million.
Meanwhile, the Department of Science and Technology (DOST) Undersecretary Rowena Cristina Guevara anticipates two or three more vaccine developers will apply for EUA in the Philippines this month.
However, Guevara noted that EUA approvals might not happen within April, as the FDA's processing takes longer than a week.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.




